Upperton Pharma Solutions Adds Large-Scale Processing following MHRA Approval at Nottingham Facility.
NOTTINGHAM, UK. July 16th, 2024 – Upperton Pharma Solutions, a contract development and manufacturing organisation (CDMO), is pleased to announce the successful completion of a Medicines and Healthcare products Regulatory Agency (MHRA) inspection at its newly commissioned 50,000 sq ft development and GMP manufacturing facility in Nottingham, UK. This milestone inspection, conducted by the UK […]